IP Library Granted Patent US 9,839,657
Granted Patent B2
US 9,839,657 · App. 14/439,866 · Granted Dec 12, 2017

Prebiotic compositions comprising one or more types of bacteriophage

Inventors: John Deaton (Kennesaw, GA); Elizabeth Ertle (Kennesaw, GA); Hilton Grant Dawson (North Fort Meyers, FL)
Assignee: DEERLAND ENZYMES, INC.
A61K35/76A61K35/742A61K35/744A61K35/745A61K35/747C12N1/20C12N7/00C12N2795/00032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,657
App. No.
14/439,866
Granted
Dec 12, 2017
Kind
B2
Abstract

Disclosed herein are compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.

Claims (11)

1. A method for increasing the growth of probiotic organisms in the digestive system of an individual, comprising administering a composition comprising a lytic bacteriophage of the Siphoviridae family and that is specific to Bacteroides fragilis and one or more probiotic organisms chosen from Lactobacillus species and Bifidobacterium species.

2. The method of claim 1 , wherein the composition comprises one or more additional bacteriophages specific to Bordetella, Borrelia, Brucella, Campylobacter, Chlamydia and Chlamydophila, Clostridium, Corynebacterium, Enterococcus, Escherichia, Francisella, Haemophilus, Helicobacter, Legionella, Leptospira, Listeria, Mycobacterium, Mycoplasma, Neisseria, Pseudomonas, Rickettsia, Salmonella, Shigella, Staphylococcus, Streptococcus, Treponema, Vibrio and Yersinia.

3. The method of claim 1 , wherein the composition further comprises one or more bacteriophages specific to E. coli B, Enterotoxigenic E. coli (ETEC), and E. coli O157:H7.

4. The method of claim 1 , wherein the probiotic organism is a Lactobacillus species.

5. The method of claim 1 , wherein the probiotic organism is L. acidophilus, L. amylovorus, L. brevis, L. casei, L. casei subsp. rhamnosus ( Lactobacillus GG), L. caucasicus, L. crispatus, L. delbrueckii subsp. bulgaricus ( L. bulgaricus ), L. fermentum ( L. fermenti ), L. gasseri, L. helveticus, L. johnsonii, L. lactis, L. leichmannii, L. paracasei, L. plantarum, L. reuteri , or L. rhamnosus.

6. The method of claim 1 , wherein the probiotic organism is a Bifidobacterium species.

7. The method of claim 1 , wherein the probiotic organism is one or more B. adolescentis, B. bifidum, B. breve, B. infantis, B. lactis ( B. animalis ), B. licheniformis , and B. longum.

8. The method of claim 1 , wherein the probiotic organism is one or more Enterococcus faecium, Lactococcus lactis, Leuconstoc mesenteroides, Pediococcus acidilactici , and Streptococcus thermophilus.

9. The method of claim 1 , wherein the probiotic organism is Bacillus subtilis, Saccharomyces boulardii , or Saccharomyces cerevisiae.

10. The method of claim 1 , wherein the composition further comprises inulin, fructooligosaccharides, galactooligiosaccharides, xylooligosaccharides, polydextrose, lactulose, tagatose, isomaltooligosaccarides, soybean oligosaccharides, lactoferrin, and proanthocyanins.

11. The method of claim 1 , wherein the amount of bacteriophage in the composition is at least 1×10 4 CFU/g.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Dec 3, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: DEERLAND PROBIOTICS & ENZYMES, INC.; NATIONAL ENZYME COMPANY, LLC
Reel/Frame 058277/0744 →
RELEASE OF SECURITY INTEREST Recorded Dec 3, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: DEERLAND PROBIOTICS & ENZYMES, INC.
Reel/Frame 058277/0753 →
SECURITY INTEREST Recorded Jun 21, 2017
From: DEERLAND ENZYMES, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 042765/0205 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2015
From: DEATON, JOHN; ERTLE, ELIZABETH; DAWSON, HILTON GRANT
To: DEERLAND ENZYMES, INC.
Reel/Frame 036254/0047 →
Continuity (2)
Provisional Application 61720121 · Oct 30, 2012
Related Publication 20150297648A1 · Oct 22, 2015